BACKGROUND: Obesity, a disorder associated with a myriad of comorbidities, is increasing at an alarming rate around the world. Given that pharmacotherapy has limited available options and that bariatric surgery is reserved for those who are morbidly obese or who have significant comorbidities, the most common approach to the treatment of obesity is standard behavioral treatment. This approach includes behavior modification related to eating and activity habits. The purpose of this paper is to describe the rationale, design, methods and baseline sample characteristics of a randomized controlled trial of a behavioral intervention in weight loss management, referred to as the PREFER study. METHODS: The PREFER study, using a four-group design, includes: (1) a randomization scheme that permits participants to indicate a preferred dietary treatment approach, and (2) two dietary options, one of which is a lacto-ovo-vegetarian diet that has demonstrated potential for long-term adherence. The intervention (32 treatment sessions) is delivered over 12 months and is followed by a 6-month maintenance phase; final assessment occurs at 18 months. RESULTS: We screened 932 individuals and randomized 197 to the study: Treatment Preference-Yes (n=84) and Treatment Preference-No (n=98). To maintain a balance across the four treatment groups, 15 subjects who preferred the standard diet had to be discarded from the Treatment Preference-Yes group. Retention at 18 months for the first of three cohorts was 82%. CONCLUSIONS: The PREFER study is a single center study and is the first randomized controlled trial examining a lacto-ovo-vegetarian diet as part of weight loss treatment. The ethnically diverse sample includes males and females with a body mass index of 27 to 43. The study has the potential to make a contribution to understanding the role of treatment preference and the potential of a lacto-ovo-vegetarian diet for long-term weight loss.
RCT Entities:
BACKGROUND:Obesity, a disorder associated with a myriad of comorbidities, is increasing at an alarming rate around the world. Given that pharmacotherapy has limited available options and that bariatric surgery is reserved for those who are morbidly obese or who have significant comorbidities, the most common approach to the treatment of obesity is standard behavioral treatment. This approach includes behavior modification related to eating and activity habits. The purpose of this paper is to describe the rationale, design, methods and baseline sample characteristics of a randomized controlled trial of a behavioral intervention in weight loss management, referred to as the PREFER study. METHODS: The PREFER study, using a four-group design, includes: (1) a randomization scheme that permits participants to indicate a preferred dietary treatment approach, and (2) two dietary options, one of which is a lacto-ovo-vegetarian diet that has demonstrated potential for long-term adherence. The intervention (32 treatment sessions) is delivered over 12 months and is followed by a 6-month maintenance phase; final assessment occurs at 18 months. RESULTS: We screened 932 individuals and randomized 197 to the study: Treatment Preference-Yes (n=84) and Treatment Preference-No (n=98). To maintain a balance across the four treatment groups, 15 subjects who preferred the standard diet had to be discarded from the Treatment Preference-Yes group. Retention at 18 months for the first of three cohorts was 82%. CONCLUSIONS: The PREFER study is a single center study and is the first randomized controlled trial examining a lacto-ovo-vegetarian diet as part of weight loss treatment. The ethnically diverse sample includes males and females with a body mass index of 27 to 43. The study has the potential to make a contribution to understanding the role of treatment preference and the potential of a lacto-ovo-vegetarian diet for long-term weight loss.
Authors: Lora E Burke; Susan M Sereika; Edvin Music; Melanie Warziski; Mindi A Styn; Arthur Stone Journal: Contemp Clin Trials Date: 2007-07-25 Impact factor: 2.226
Authors: Ran Sun; Jeffrey M Rohay; Susan M Sereika; Yaguang Zheng; Yang Yu; Lora E Burke Journal: Obesity (Silver Spring) Date: 2019-03-06 Impact factor: 5.002
Authors: Nancy Lu; Shalkar Adambekov; Robert P Edwards; Ramesh C Ramanathan; Dana H Bovbjerg; Faina Linkov Journal: Bariatr Surg Pract Patient Care Date: 2019-09-24 Impact factor: 0.607
Authors: Lora E Burke; Mindi A Styn; Susan M Sereika; Molly B Conroy; Lei Ye; Karen Glanz; Mary Ann Sevick; Linda J Ewing Journal: Am J Prev Med Date: 2012-07 Impact factor: 5.043
Authors: Faina Linkov; Lora E Burke; Marina Komaroff; Robert P Edwards; Anna Lokshin; Mindi A Styn; Eugene Tseytlin; Kyle E Freese; Dana H Bovbjerg Journal: Gynecol Oncol Date: 2014-01-22 Impact factor: 5.482
Authors: Sushama D Acharya; Okan U Elci; Susan M Sereika; Edvin Music; Mindi A Styn; Melanie Warziski Turk; Lora E Burke Journal: Patient Prefer Adherence Date: 2009-11-03 Impact factor: 2.711